Background: Sensitivity to birch pollen allergens is a common feature among European patients with seasonal pollen allergy. In this in vitro study, we examined the specific serum IgE binding profiles to individual birch pollen allergens in birch-sensitive patients from six European populations. Methods: The study included 242 patients from Finland, Sweden, Austria, France, Switzerland and Italy. All suffered from seasonal rhinoconjunctivitis and/or asthma. Their sera were analyzed for specific IgE reactivity to individual birch pollen allergens (recombinant Bet v 1, Bet v 2 and Bet v 4) and natural birch pollen extract using Pharmacia CAP System™ and immunoblotting. Results: Almost all Finnish, Swedish and Austrian sera contained IgE specific for Bet v 1 (≧98%). Bet v 1-specific IgE antibodies were found in 90% of the French sera, and in 65 and 62% of the sera from Switzerland and Italy, respectively. Few Finnish (2%) and Swedish (12%) patients had IgE to Bet v 2, while Bet v 2 reactivity was more common in the other populations (20–43%). Reactivity to Bet v 4 was rare in all populations (5–11%) except for the Italian patients, in whom 3 of 11 sera were positive (27%). The immunoblot results supported the specific IgE profiles obtained with Pharmacia CAP System showing a broader IgE reactivity profile in patients from central and southern Europe as compared to northern Europe. Conclusion: Component-resolved allergy diagnosis with recombinant allergens reveals that the IgE reactivity profiles to individual birch pollen allergens vary between European populations. This observation may be explained by sensitization to different allergen sources and will have an impact on allergen-specific prevention and therapy strategies.

Keywords:
Bet v 1, Bet v 2, Bet v 4, Birch pollen, Immunoblotting, Pharmacia CAP System, Recombinant allergens
1.
D’Amato G, Spieksma FTM, Liccardi G, Jager S, Russo M, Kontou-Fili K, Nikkels H, Wuthrich B, Bonini S: Pollen-related allergy in Europe. Allergy 1998;53:567–578.
2.
Jarolim E, Rumpold H, Endler AT, Ebner H, Breitenbach M, Scheiner O, Kraft D: IgE and IgG antibodies of patients with allergy to birch pollen as tools to define the allergen profile of Betula verrucosa. Allergy 1989;44:385–395.
3.
Breiteneder H, Pettenburger K, Bito A, Valenta R, Kraft D, Rumpold H, Scheiner O, Breitenbach M: The gene coding for the major birch pollen allergen Betv1 is highly homologous to a pea disease resistance response gene. EMBO J 1989;8:1935–1938.
4.
Valenta R, Duchene M, Pettenburger K, Sillaber C, Valent P, Bettelheim P, Breitenbach M, Rumpold H, Kraft D, Scheiner O: Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals. Science 1991;253:557–560.
5.
Seiberler S, Scheiner O, Kraft D, Lonsdale D, Valenta R: Characterization of a birch pollen allergen, Bet v III, representing a novel class of Ca2+ binding proteins: Specific expression in mature pollen and dependence of patients’ IgE binding on protein-bound Ca2+. EMBO J 1994;13:3481–3486.
6.
Twardosz A, Hayek B, Seiberler S, Vangelista L, Elfman L, Gronlund H, Kraft D, Valenta R: Molecular characterization, expression in Escherichia coli, and epitope analysis of a two EF-hand calcium-binding birch pollen allergen, Bet v 4. Biochem Biophys Res Commun 1997;239:197–204.
7.
Karamloo F, Wangorsch A, Kasahara H, Davin LB, Haustein D, Lewis NG, Vieths S: Phenylcoumaran benzylic ether and isoflavonoid reductases are a new class of cross-reactive allergens in birch pollen, fruits and vegetables. Eur J Biochem 2001;268:5310–5320.
8.
Valenta R, Sperr WR, Ferreira F, Valent P, Sillaber C, Tejkl M, Duchene M, Ebner C, Lechner K, Kraft D, Scheiner O: Induction of specific histamine release from basophils with purified natural and recombinant birch pollen allergens. J Allergy Clin Immunol 1993;91:88–97.
9.
Valenta R, Duchene M, Vrtala S, Birkner T, Ebner C, Hirschwehr R, Breitenbach M, Rumpold H, Scheiner O, Kraft D: Recombinant allergens for immunoblot diagnosis of tree-pollen allergy. J Allergy Clin Immunol 1991;88:889–894.
10.
Rossi RE, Monasterolo G, Operti D, Corsi M: Evaluation of recombinant allergens Bet v 1 and Bet v 2 (profilin) by Pharmacia CAP System in patients with pollen-related allergy to birch and apple. Allergy 1996;51:940–945.
11.
Scheiner O, Aberer W, Ebner C, Ferreira F, Hoffmann-Sommergruber K, Hsieh LS, Kraft D, Sowka S, Vanek-Krebitz M, Breiteneder H: Cross-reacting allergens in tree pollen and pollen-related food allergy: Implications for diagnosis of specific IgE. Int Arch Allergy Immunol 1997;113:105–108.
12.
Valenta R, Duchene M, Ebner C, Valent P, Sillaber C, Deviller P, Ferreira F, Tejkl M, Edelmann H, Kraft D, Scheiner O: Profilins constitute a novel family of functional plant pan-allergens. J Exp Med 1992;175:377–385.
13.
Pauli G, Oster JP, Deviller P, Heiss S, Bessot JC, Susani M, Ferreira F, Kraft D, Valenta R: Skin testing with recombinant allergens rBet v 1 and birch profilin, rBet v 2: Diagnostic value for birch pollen and associated allergies. J Allergy Clin Immunol 1996;97:1100–1109.
14.
Seiberler S, Scheiner O, Kraft D, Valenta R: Homology of two cDNA coding for birch pollen allergens with calmodulin: Protein-bound Ca2+ affects the IgE-binding capacity. Int Arch Allergy Immunol 1992;99:380–381.
15.
Cadot P, Diaz JF, Proost P, Van DJ, Engelborghs Y, Stevens EA, Ceuppens JL: Purification and characterization of an 18-kd allergen of birch (Betula verrucosa) pollen: Identification as a cyclophilin. J Allergy Clin Immunol 2000;105:286–291.
16.
Mahler V, Fischer S, Heiss S, Duchene M, Kraft D, Valenta R: cDNA cloning and characterization of a cross-reactive birch pollen allergen: Identification as a pectin esterase. Int Arch Allergy Immunol 2001;124:64–66.
17.
Laffer S, Spitzauer S, Susani M, Pairleitner H, Schweiger C, Gronlund H, Menz G, Pauli G, Ishii T, Nolte H, Ebner C, Sehon AH, Kraft D, Eichler HG, Valenta R: Comparison of recombinant timothy grass pollen allergens with natural extract for diagnosis of grass pollen allergy in different populations. J Allergy Clin Immunol 1996;98:652–658.
18.
Elfman L, Svensson M, Lidholm J, Pauli G, Valenta R: Different profiles in specific IgE to rBet v 1 and rBet v 2 in patients allergic to birch pollen from six countries. Int Arch Allergy Immunol 1997;113:249–251.
19.
Moverare R, Sorva R, Metso T, Vesterinen E, Elfman L, Haahtela T: Pollen-specific rush immunotherapy: Clinical efficacy and effects on antibody concentrations. Ann Allergy Asthma Immunol 2001;86:337–342.
20.
Fogle-Hansson M, Bende M: The significance of hypersensitivity to nuts in patients with birch pollen allergy. Allergy 1993;48:282–284.
21.
Leimgruber A, Mosimann B, Claeys M, Seppey M, Jaccard Y, Aubert V, Peitrequin R, Nisoli MP, Pecoud A: Clinical evaluation of a new in-vitro assay for specific IgE, the immuno CAP system. Clin Exp Allergy 1991;21:127–131.
22.
Pastorello EA, Incorvaia C, Pravettoni V, Marelli A, Farioli L, Ghezzi M: Clinical evaluation of CAP System and RAST in the measurement of specific IgE. Allergy 1992;47:463–466.
23.
Engel E, Richter K, Obermeyer G, Briza P, Kungl AJ, Simon B, Auer M, Ebner C, Rheinberger HJ, Breitenbach M, Ferreira F: Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains. J Biol Chem 1997;272:28630–28637.
24.
Neville DM Jr: Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem 1971;246:6328–6334.
25.
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 1979;76:4350–4354.
26.
Menz G, Dolecek C, Schonheit Kenn U, Ferreira F, Moser M, Schneider T, Suter M, Boltz Nitulescu G, Ebner C, Kraft D, Valenta R: Serological and skin-test diagnosis of birch pollen allergy with recombinant Bet v I, the major birch pollen allergen. Clin Exp Allergy 1996;26:50–60.
27.
Troise C, Voltolini S, Delbono G, Negrini AC: Allergy to pollens from Betulaceae and Corylaceae in a Mediterranean area (Genoa, Italy) – A ten-year retrospective study. J Investig Allergol Clin Immunol 1992;2:313–317.
28.
Jilek A, Swoboda I, Breiteneder H, Fogy I, Ferreira F, Schmid E, Heberle-Bors E, Scheiner O, Rumpold H, et al: Biological functions, isoforms and environmental control in the Bet v 1 gene family; in Kraft D, Sehon A (eds): Molecular Biology and Immunology of Allergens. Boca Raton, CRC Press, 1993, pp 39–45.
29.
Arntzen FC, Wilhelmsen TW, Lowenstein H, Gjesing B, Maasch HJ, Stromberg R, Einarsson R, Backman A, Makinen-Kiljunen S, Ford A: The international collaborative study on the first international standard of birch (Betula verrucosa)-pollen extract. J Allergy Clin Immunol 1989;83:66–82.
30.
Ebner C, Birkner T, Valenta R, Rumpold H, Breitenbach M, Scheiner O, Kraft D: Common epitopes of birch pollen and apples – Studies by Western and Northern blot. J Allergy Clin Immunol 1991;88:588–594.
31.
van Ree R, Fernandez Rivas M, Cuevas M, van Wijngaarden M, Aalberse RC: Pollen-related allergy to peach and apple: An important role for profilin. J Allergy Clin Immunol 1995;95:726–734.
32.
Daschner A, Crespo JF, Pascual CY: Specific IgE to recombinant vegetal panallergen (rBet v 2) and fruit allergy in pollinic patients. Allergy 1998;53:614–618.
33.
Ebner C, Hirschwehr R, Bauer L, Breiteneder H, Valenta R, Ebner H, Kraft D, Scheiner O: Identification of allergens in fruits and vegetables: IgE cross-reactivities with the important birch pollen allergens Bet v 1 and Bet v 2 (birch profilin). J Allergy Clin Immunol 1995;95:962–969.
34.
Kazemi-Shirazi L, Pauli G, Purohit A, Spitzauer S, Fröschl R, Hoffmann-Sommergruber K, Breiteneder H, Scheiner O, Kraft D, Valenta R: Quantitative IgE inhibition experiments with purified recombinant allergens indicate pollen-derived allergens as the sensitizing agents responsible for many forms of plant food allergy. J Allergy Clin Immunol 2000;105:116–125.
35.
Helbling A, Lopez M, Schwartz HJ, Lehrer SB: Reactivity of carrot-specific IgE antibodies with celery, apiaceous spices, and birch pollen. Ann Allergy 1993;70:495–499.
36.
Hirschwehr R, Valenta R, Ebner C, Ferreira F, Sperr WR, Valent P, Rohac M, Rumpold H, Scheiner O, Kraft D: Identification of common allergenic structures in hazel pollen and hazelnuts: A possible explanation for sensitivity to hazelnuts in patients allergic to tree pollen. J Allergy Clin Immunol 1992;90:927–936.
37.
Diez-Gomez ML, Quirce S, Cuevas M, Sanchez-Fernandez C, Baz G, Moradiellos FJ, Martinez A: Fruit-pollen-latex cross-reactivity: Implication of profilin (Bet v 2). Allergy 1999;54:951–961.
38.
Pettenburger K, Tejkl M, Valenta R, Hoffmann-Sommergruber K, Swoboda I, Heberle-Bors E, Breitenbach M, Rumpold H, Kraft D, Scheiner O: Distribution of allergens and allergen-coding mRNAs in various tissues of white birch. Mol Immunol 1992;29:1401–1406.
39.
Ledesma A, Villalba M, Batanero E, Rodriguez R: Molecular cloning and expression of active Ole e 3, a major allergen from olive-tree pollen and member of a novel family of Ca2+-binding proteins (polcalcins) involved in allergy. Eur J Biochem 1998;258:454–459.
40.
Ledesma A, Rodriguez R, Villalba M: Olive-pollen profilin: Molecular and immunologic properties. Allergy 1998;53:520–526.
41.
Valenta R, Lidholm J, Niederberger V, Hayek B, Kraft D, Gronlund H: The recombinant allergen-based concept of component-resolved diagnostics and immunotherapy (CRD and CRIT). Clin Exp Allergy 1999;29:896–904.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.